CNBX Pharmaceuticals Inc.
CNBX· OTC
CNBXCNBX Pharmaceuticals Inc.
Filed Jan 20, 2015 · 10-Q · 51 days after period end · 0001019687-15-000244
| Metric | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|
| Net Income | -$127.66K | -$13.34K | -$15.14K | -$10.25K |
| EPS Diluted | $0.00 | $0.00 | -$0.02 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CNBX Pharmaceuticals Inc. · CIK 1343009 · Engraved from SEC EDGAR
ended Nov 30, 2014 · filed Jan 20, 2015 · 51 d after period end
